Skip to main content
. Author manuscript; available in PMC: 2016 Apr 15.
Published in final edited form as: J Immunol. 2012 Oct 3;189(10):5029–5036. doi: 10.4049/jimmunol.1201892

Table 4.

Mulvariate analyses of Hazard Ratios with Relapse-free Survival and Overall Survival in breast cancer patients (n=81).

Variables Relapse-free Survival
Overall survival
HR 95% CI p HR 95% CI p
γδ T (>9) 34.68 4.79 to 250.88 0.0004 3.34 1.21 to 9.25 0.020
FoxP3 (>12) 3.08 0.49 to 19.17 0.228 3.05 0.95 to 9.77 0.061
CD4 (>16) 2.31 0.66 to 8.07 0.189 1.20 0.47 to 3.09 0.702
CD8 (>13) 0.04 0.01 to 0.35 0.004 0.47 0.18 to 1.27 0.137
Stage (III vs I + II) 5.24 1.25 to 22.02 0.023 2.17 0.83 to 5.67 0.114
Nodal (Pos) 2.36 0.32 to 17.59 0.404 1.99 0.54 to 7.31 0.301

Note: Results obtained using the Cox proportional hazard regression model.

Abbreviations: HR, hazard ratio; FoxP3, forkhead box protein P3.

HHS Vulnerability Disclosure